Related Experiment Video
Updated: Feb 11, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
Prognostic value of systemic immune-inflammation index and prognostic nutritional index in advanced prostate cancer:
Gao Li1, Boxiao Li1, Xin Zhang2
1Department of Urology, Beijing Chao-Yang Hospital Affiliated to Capital Medical University, No. 5 JingYuan Road, ShiJingShan District, Beijing, 100043, China.
Abstract:
BACKGROUND: The systemic immune-inflammation index (SII) and prognostic nutritional index (PNI) have emerged as potential prognostic markers in various malignancies, but their combined and interactive value in advanced prostate cancer (PCa) remains underexplored. METHODS: This retrospective cohort study included 115 patients with advanced PCa (American Joint Committee on Cancer(AJCC) stage III–IV) diagnosed between January 2016 and December 2020. SII and PNI were calculated from pretreatment blood samples. Restricted cubic spline (RCS) analysis was used to explore nonlinear relationships. Cox regression identified independent prognostic factors. A nomogram incorporating AJCC stage, SII, and PNI was developed to predict 1-, 3-, and 5-year overall survival (OS). The model was internally validated via bootstrapping, with calibration and decision curve analysis (DCA) assessing accuracy and clinical utility. RESULTS: With a median follow-up of 54 months, SII and PNI predicted OS with AUCs of 0.712 and 0.803, respectively. RCS analysis revealed nonlinear, J-shaped (SII) and reverse S-shaped (PNI) relationships with OS and progression-free survival (PFS) risks (P < 0.001). Multivariate Cox analysis confirmed AJCC stage IV (HR = 2.18, 95% CI: 1.02–4.65), SII ≥ 671.70 (HR = 2.43, 95% CI: 1.42–4.15), and PNI < 46.35 (HR = 3.85, 95% CI: 2.25–6.59) as independent risk factors. A significant synergistic interaction was observed (interaction HR = 1.85, 95% CI: 1.11–3.08, P = 0.018). The nomogram achieved a C-index of 0.861 and an AUC of 0.874 for 3-year OS prediction, outperforming individual markers (P < 0.05). Calibration plots showed excellent agreement, and DCA demonstrated positive net clinical benefit across a wide threshold probability range. CONCLUSION: Pretreatment SII and PNI are synergistic and independent prognostic markers for advanced PCa, exhibiting nonlinear relationships with survival outcomes. The developed nomogram provides accurate, individualized survival probability estimation with favorable clinical utility, serving as a practical tool for risk stratification and personalized treatment planning.
Related Concept Videos
Inflammation
The Roles of Bacteria and Fungi in Plant Nutrition
Reliability and Validity
In Vitro Drug Release Testing: Overview, Development and Validation
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Microbial Nutrition

